Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori.
AUTOR(ES)
Phillips, K
RESUMO
The urease inhibitor acetohydroxamic acid (AHA) was assessed for its bacteriostatic and bactericidal effects on Helicobacter pylori. For eight isolates of H pylori, the minimum inhibitory concentration (MIC) was either 200 mg/l or 400 mg/l. Interactions between AHA and antimicrobial drugs used to treat H pylori were also determined. For most isolates AHA reduced the MIC for colloidal bismuth subcitrate (CBS), tetracycline, metronidazole, and amoxicillin. In a few isolates, however, AHA increased the minimum bactericidal concentration (MBC) for these antimicrobial treatments. In vitro AHA is active against H pylori and it interacts with other agents directed against H pylori.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=501224Documentos Relacionados
- Urease activity of Helicobacter pylori.
- Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid.
- Urease-associated heat shock protein of Helicobacter pylori.
- Purification and N-terminal analysis of urease from Helicobacter pylori.
- Cytotoxic activity of Helicobacter pylori enhanced by acetohydroxamic acid.
